Document is current
Any future updates will be listed below
-
Authors
Suppan, Christoph https://orcid.org/0000-0003-0284-3848
-
Funding
Funding for this research was provided by:
Medical University of Graz
- License Information
-
More Information
Article History
Received: 11 January 2026
Accepted: 23 March 2026
First Online: 20 April 2026
Conflict of interest
: C. Suppan: Consulting or Advisory Role: Roche, Novartis, Pfizer, Eli Lilly, Astra Zeneca, Gilead, Daiichi Sankyo, Pierre Fabre; Speakers’ Bureau: Roche, Novartis, Pfizer, Eli Lilly, Pierre Fabre, Astra Zeneca, Gilead, Daiichi Sankyo, Stemline Menarini; Travel, Accommodations, Expenses: Roche, Novartis, Pfizer, Astellas, Astra Zeneca, Daiichi Sankyo, Pierre Fabre.
